Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The larvicidal efficacy and mechanism of action of 5-Ethenyl-2,2'-bithiophene extracted from Echinops ritro on Aedes aegypti larvae.

Created on 01 Aug 2024

Authors

Quan Meirong

Published in

Pesticide biochemistry and physiology. Volume 203. Pages 105965. Epub May 31, 2024.

Abstract

Herein, we focused on the larvicidal effects and potential mechanisms of 5-ethenyl-2,2'-bithiophene (5 EB), a compound isolated from Echinops ritro L. on Aedes aegypti larvae. Our results show that 5 EB exhibits pronounced larvicidal activity against A. aegypti larvae, with an LC50 = 0.24 mg/L, considerably lesser than that of the traditional insecticide, rotenone. Observations using fluorescence microscopy, electron microscopy, and imaging flow cytometry demonstrated that 5 EB targets the hemocytes of larvae, leading to the disruption of their intracellular membrane systems. This disruption leads to considerable damage to the cellular structure and function, leading to the death of test subjects. Note that additional investigation into the molecular mechanism of 5 EB's action was conducted using transcriptomic analysis. Both GO and KEGG enrichment analyses reported that the differentially expressed genes were predominantly associated with membranes, lysosomes, and catalytic activities. To summarize, this study provides new options for developing new, environmentally friendly, plant-based larvicides for mosquito control.

PMID:
39084763
Bibliographic data and abstract were imported from PubMed on 01 Aug 2024.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 85
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement